News
A novel dual Janus kinase/protein kinase inhibitor alleviates rheumatoid arthritis at higher doses without causing lipid or creatine kinase changes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback